Table 6.
Nuclear ERβ expression is lower in triple-negative patients.
| Outcome | Median (Minimum, maximum) | P value* | |
|---|---|---|---|
| TNBC (N = 45) | All other subtypes (N = 153) | ||
| ERβ (freq) (n) | 0 (0, 4) | 2 (0, 4) | 0.022† |
| ERβ (int) (n) | 0 (0, 4) | 1 (0, 4) | 0.024† |
| ERβ (freq) (c) | 3 (1, 3) | 3 (2, 4) | 0.079 |
| ERβ (int) (c) | 1 (1, 3) | 1 (1, 4) | 0.378 |
*P value is based on the Wilcoxon Rank-(sum) test. n: nuclear; c: cytoplasmic;
† P value < 0.05.